In May 2007, FDA announced approval of Neupro (rotigotine transdermal system), a skin patch designed to treat symptoms of early Parkinson's Disease.
On May 9, 2007, FDA announced the approval of Neupro (rotigotine transdermal system), a skin ...
More Information
On May 9, 2007, FDA announced the approval of Neupro (rotigotine transdermal system), a skin ...
More Information